• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Reply to the Letter to the Editor by Kessler Y et al. regarding the manuscript "Safety profile of erenumab, galcanezumab and fremanezumab in pregnancy and lactation: Analysis of the WHO pharmacovigilance database.".

作者信息

Noseda Roberta, Bedussi Francesca, Gobbi Claudio, Zecca Chiara, Ceschi Alessandro

机构信息

Division of Clinical Pharmacology and Toxicology, Institute of Pharmacological Sciences of Southern Switzerland, Ente Ospedaliero Cantonale, Lugano, Switzerland.

Neurocenter of Southern Switzerland, Ente Ospedaliero Cantonale, Lugano, Switzerland.

出版信息

Cephalalgia. 2021 Sep;41(10):1130-1131. doi: 10.1177/03331024211006849. Epub 2021 May 2.

DOI:10.1177/03331024211006849
PMID:33938247
Abstract
摘要

相似文献

1
Reply to the Letter to the Editor by Kessler Y et al. regarding the manuscript "Safety profile of erenumab, galcanezumab and fremanezumab in pregnancy and lactation: Analysis of the WHO pharmacovigilance database.".回复凯斯勒等人致编辑的信，信中涉及手稿《erenumab、galcanezumab和fremanezumab在妊娠和哺乳期的安全性概况：世界卫生组织药物警戒数据库分析》。
Cephalalgia. 2021 Sep;41(10):1130-1131. doi: 10.1177/03331024211006849. Epub 2021 May 2.
2
Letter to the editor regarding "Safety profile of erenumab, galcanezumab and fremanezumab in pregnancy and lactation: Analysis of the WHO pharmacovigilance database".致编辑的信：关于“erenumab、galcanezumab和fremanezumab在妊娠和哺乳期的安全性概况：世界卫生组织药物警戒数据库分析”
Cephalalgia. 2021 Sep;41(10):1128-1129. doi: 10.1177/03331024211006827. Epub 2021 May 2.
3
Safety profile of erenumab, galcanezumab and fremanezumab in pregnancy and lactation: Analysis of the WHO pharmacovigilance database.妊娠和哺乳期依瑞奈单抗、加兰他敏和弗雷马泽单抗的安全性概况：世界卫生组织药物警戒数据库分析。
Cephalalgia. 2021 Jun;41(7):789-798. doi: 10.1177/0333102420983292. Epub 2021 Jan 12.
4
Cost of fremanezumab, erenumab, galcanezumab and onabotulinumtoxinA associated adverse events, for migraine prophylaxis in Spain.在西班牙，用于偏头痛预防的 fremanezumab、erenumab、galcanezumab 和 onabotulinumtoxinA 相关不良事件的成本。
Expert Rev Pharmacoecon Outcomes Res. 2021 Apr;21(2):285-297. doi: 10.1080/14737167.2020.1768850. Epub 2020 Jun 2.
5
Safety and tolerability of calcitonin-gene-related peptide binding monoclonal antibodies for the prevention of episodic migraine - a meta-analysis of randomized controlled trials.降钙素基因相关肽结合单克隆抗体预防阵发性偏头痛的安全性和耐受性-随机对照试验的荟萃分析。
Cephalalgia. 2019 Aug;39(9):1164-1179. doi: 10.1177/0333102419829007. Epub 2019 Feb 21.
6
Hypersensitivity to galcanezumab with tolerance to erenumab and fremanezumab.对加卡奈单抗过敏，但对依瑞奈单抗和夫瑞奈单抗耐受。
J Allergy Clin Immunol Pract. 2023 Aug;11(8):2614-2615. doi: 10.1016/j.jaip.2023.05.008. Epub 2023 May 16.
7
European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention.欧洲头痛联合会关于使用作用于降钙素基因相关肽或其受体的单克隆抗体预防偏头痛的指南。
J Headache Pain. 2019 Jan 16;20(1):6. doi: 10.1186/s10194-018-0955-y.
8
Eptinezumab (Vyepti) for migraine prevention.依普他命单抗（Vyepti）用于预防偏头痛。
Med Lett Drugs Ther. 2020 Jun 1;62(1599):85-87.
9
Medications Approved for Preventing Migraine Headaches.预防偏头痛的药物获批。
Am J Med. 2020 Jun;133(6):664-667. doi: 10.1016/j.amjmed.2020.01.031. Epub 2020 Mar 5.
10
In brief: Erenumab (Aimovig) hypersensitivity.简而言之：依瑞卡单抗（安进公司的Aimovig）过敏反应。
Med Lett Drugs Ther. 2019 Mar 25;61(1568):48.